Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes

investors.com/news/technology/incyte-stock-bill-meury-herve-hoppenot-ceo/?src=A00220

stock popped Thursday after the company's board appointed Bill Meury as its new chief executive officer, replacing Herve Hoppenot, who is retiring after 11 years.
Meury has a long history in the biopharma space, particularly when it comes to takeovers. He previously headed up Anthos…

This story appeared on investors.com, 2025-06-26 13:11:51.
The Entire Business World on a Single Page. Free to Use →